References
- Benoit MH, Hudson TJ, Maire G, et al. (2007). Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol 30:5–17
- Brockdorff N. (2011). Chromosome silencing mechanisms in X-chromosome inactivation: unknown unknowns. Development 138:5057–65
- Carrel L, Willard HF. (2005). X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400–4
- Chomczynski P, Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 162:156–9
- Eyre TA, Ducluzeau F, Sneddon TP, et al. (2006). The HUGO Gene Nomenclature Database, 2006 updates. Nucleic Acids Res 34:D319–21
- Fiegler H, Redon R, Andrews D, et al. (2006). Accurate and reliable high-throughput detection of copy number variation in the human genome. Genome Res 16:1566–74
- Fisher EM, Beer-Romero P, Brown LG, et al. (1990). Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome. Cell 63:1205–18
- Foresta C, Ferlin A, Moro E. (2000). Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet 9:1161–9
- Galfalvy HC, Erraji-Benchekroun L, Smyrniotopoulos P, et al. (2003). Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics 4:37
- Goldberg SI, Niemierko A, Turchin A. (2008). Analysis of data errors in clinical research databases. AMIA Annual Symp Proc 6:242–6
- Goodsaid F. (2012). Challenges of biomarkers in drug discovery and development. Expert Opin Drug Discov 7:457–61
- Goodsaid F, Frueh F. (2006). Process map proposal for the validation of genomic biomarkers. Pharmacogenomics 7:773–82
- Hughes JF, Rozen S. (2012). Genomics and genetics of human and primate y chromosomes. Annu Rev Genomics Hum Genet 13:83–108
- Isensee J, Ruiz Noppinger P. (2007). Sexually dimorphic gene expression in mammalian somatic tissue. Gend Med 4:S75–95
- Jiang B, Tan AS, Chong SS. (2012). Molecular strategies for pre-implantation genetic diagnosis of single gene and chromosomal disorders. Best Pract Res Clin Obstet Gynaecol 26:551–9
- Karchin R, Monteiro AN, Tavtigian SV, et al. (2007). Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS Comput Biol 3:e26
- Karyagyna AS, Vassiliev MO, Ershova AS, et al. (2010). Probe-Level Universal Search (PLUS) algorithm for gender differentiation in affymetrix datasets. J Bioinform Comput Biol 8:553–77
- Lahn BT, Page DC. (1997). Functional coherence of the human Y chromosome. Science 278:675–80
- Lockhart DJ, Dong H, Byrne MC, et al. (1996). Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675–80
- MacKay DJC. (2002). Information theory, inference & learning algorithms. New York: Cambridge University Press. ISBN-10: 0521642981
- Marrer E, Dieterle F. (2007). Promises of biomarkers in drug development – a reality check. Chem Biol Drug Des 69:381–94
- May KO. (1952). A set of independent necessary and sufficient conditions for simple majority decision. Econometrica 20:680–4
- Paulsen M. (2011). Unique patterns of evolutionary conservation of imprinted genes. Clin Epigenetics 2:405–10
- Penrose LS. (1946). The elementary statistics of majority voting. J R Stat Soc 109:53–7
- Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B. (2002). Xist RNA and the mechanism of X chromosome inactivation. Ann Rev Genet 36:233–78
- Quackenbush J. (2002). Microarray data normalization and transformation. Nat Genet 32:496–501
- Reynolds R, Varlaro J. (1996). Gender determination of forensic samples using PCR amplification of ZFX/ZFY gene sequences. J Forensic Sci 41:279–86
- Sirchia SM, Ramoscelli L, Grati FR, et al. (2005). Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 65:2139–46
- Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, et al. (2003). The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423:825–37
- Talebizadeh Z, Simon SD, Butler MG. (2006). X chromosome gene expression in human tissues: male and female comparisons. Genomics 88:675–81
- Tang Y, Lu A, Ran R, et al. (2004). Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. Brain Res Mol Brain 132:155–67
- Tattermusch A, Brockdorff N. (2011). A scaffold for X chromosome inactivation. Hum Genet 130:247–53
- US Food and Drug Administration. (2005). Guidance for industry pharmacogenomic data submissions. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126957.pdf [last accessed 28 May 2013]
- US Food and Drug Administration. Table of valid genomic biomarkers in the context of approved drug labels. Available at: http://www.fda.gov/cder/genomics/genomic_biomarkers_table.htm [last accessed 28 May 2013]
- Vawter MP, Evans S, Choudary P, et al. (2004). Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 29:373–84
- Williams PM, Lively TG, Jessup JM, Conley BA. (2012). Bridging the gap: moving predictive and prognostic assays from research to clinical use. Clin Cancer Res 18:1531–9
- Williams SA, Slavin DE, Wagner JA, Webster CJ. (2006). A cost-effectiveness approach to the qualification and acceptance of biomarkers. Nat Rev Drug Discov 5:897–902
- Wit E, McClure J. (2004). Statistics for microarrays. Design, analysis and inference. West Sussex, UK: John Wiley & Sons. ISBN-10: 0470849932